Haibo Wu

4.3k total citations
100 papers, 2.5k citations indexed

About

Haibo Wu is a scholar working on Molecular Biology, Immunology and Infectious Diseases. According to data from OpenAlex, Haibo Wu has authored 100 papers receiving a total of 2.5k indexed citations (citations by other indexed papers that have themselves been cited), including 52 papers in Molecular Biology, 18 papers in Immunology and 16 papers in Infectious Diseases. Recurrent topics in Haibo Wu's work include SARS-CoV-2 and COVID-19 Research (12 papers), MicroRNA in disease regulation (9 papers) and CRISPR and Genetic Engineering (7 papers). Haibo Wu is often cited by papers focused on SARS-CoV-2 and COVID-19 Research (12 papers), MicroRNA in disease regulation (9 papers) and CRISPR and Genetic Engineering (7 papers). Haibo Wu collaborates with scholars based in China, Germany and Egypt. Haibo Wu's co-authors include Beibei Fu, Jiamin Zhao, Jingcheng Zhang, Xiaoyuan Lin, Wei Peng, Weiwei Xue, Songna Yin, Yongsheng Wang, Yong Zhang and Na Xing and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nucleic Acids Research and Nature Communications.

In The Last Decade

Haibo Wu

93 papers receiving 2.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Haibo Wu China 28 1.2k 474 273 268 267 100 2.5k
Xin Jiang China 27 1.9k 1.6× 506 1.1× 429 1.6× 367 1.4× 239 0.9× 138 3.4k
Christiane V. Löhr United States 33 1.2k 1.0× 186 0.4× 357 1.3× 337 1.3× 309 1.2× 143 3.2k
Brigitta Buttari Italy 34 1.3k 1.1× 276 0.6× 189 0.7× 779 2.9× 124 0.5× 96 4.0k
Han Li China 25 986 0.8× 263 0.6× 124 0.5× 171 0.6× 239 0.9× 80 2.6k
Elisabetta Profumo Italy 38 1.3k 1.1× 415 0.9× 176 0.6× 782 2.9× 95 0.4× 99 4.3k
Kaori Tanaka Japan 29 2.0k 1.7× 201 0.4× 375 1.4× 192 0.7× 222 0.8× 182 3.7k
Chia‐Ling Chen Taiwan 34 1.5k 1.3× 268 0.6× 237 0.9× 621 2.3× 88 0.3× 118 3.1k
Hee‐Jae Cha South Korea 32 1.5k 1.3× 146 0.3× 333 1.2× 343 1.3× 120 0.4× 151 3.1k

Countries citing papers authored by Haibo Wu

Since Specialization
Citations

This map shows the geographic impact of Haibo Wu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Haibo Wu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Haibo Wu more than expected).

Fields of papers citing papers by Haibo Wu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Haibo Wu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Haibo Wu. The network helps show where Haibo Wu may publish in the future.

Co-authorship network of co-authors of Haibo Wu

This figure shows the co-authorship network connecting the top 25 collaborators of Haibo Wu. A scholar is included among the top collaborators of Haibo Wu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Haibo Wu. Haibo Wu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wu, Haibo, et al.. (2025). GeoRRDI: An explainable and multi-source data-driven framework for rural revitalization assessment with spatial heterogeneity consideration. Ecological Indicators. 181. 114387–114387. 1 indexed citations
2.
Zheng, Chengyou, Zheng‐Yi Zhou, Haibo Wu, et al.. (2025). Superior diagnostic performance of Grocott methenamine silver staining in pulmonary cryptococcosis: a multicenter, large-sample cohort study. Frontiers in Microbiology. 16. 1615057–1615057.
3.
Yu, Haiyang, Xin Sun, Yan Li, et al.. (2025). Macrophage NLRP3 activation and IL-1β release drive osimertinib-induced antitumor immunity. Journal for ImmunoTherapy of Cancer. 13(10). e012182–e012182. 1 indexed citations
4.
Sha, Zhou, et al.. (2025). Repurposing drugs for the human dopamine transporter through WHALES descriptors-based virtual screening and bioactivity evaluation. Journal of Pharmaceutical Analysis. 15(8). 101368–101368. 2 indexed citations
5.
Lu, Xiaoxue, Bohao Li, Shiyao Xu, et al.. (2025). Bacteroides Fragilis Transplantation Reverses Reproductive Senescence by Transporting Extracellular Vesicles Through the Gut‐Ovary Axis. Advanced Science. 12(9). e2409740–e2409740. 6 indexed citations
6.
Zhang, Xiang, et al.. (2024). Exploring gut microbial metabolites as key players in inhibition of cancer progression: Mechanisms and therapeutic implications. Microbiological Research. 288. 127871–127871. 6 indexed citations
7.
Li, Bohao, et al.. (2024). The gut-reproductive axis: Bridging microbiota balances to reproductive health and fetal development. International Immunopharmacology. 144. 113627–113627. 4 indexed citations
8.
Wu, Haibo, et al.. (2024). Thoracic SMARCA4-Deficient Undifferentiated Tumor Mimicking Malignant Pleural Mesothelioma on FDG PET/CT. Clinical Nuclear Medicine. 49(10). 978–980.
9.
Zhang, Yang, et al.. (2024). Structural Models of Human Norepinephrine Transporter Ensemble Reveal the Allosteric Sites and Ligand-Binding Mechanism. The Journal of Physical Chemistry B. 128(36). 8651–8661. 8 indexed citations
10.
Xiong, Yan, et al.. (2024). Cell-Penetrating Peptides in infection and immunization. Microbiological Research. 290. 127963–127963. 2 indexed citations
11.
Xiong, Yan, Lulu Wang, Shiyao Xu, et al.. (2023). Small molecule Z363 co‐regulates TAF10 and MYC via the E3 ligase TRIP12 to suppress tumour growth. Clinical and Translational Medicine. 13(1). e1153–e1153. 6 indexed citations
12.
Paul, Debasish, Bei Li, Ahmed Redwan Haque, et al.. (2023). Biofertilizer science and practice for agriculture and forestry: A review. Journal of Applied Biology & Biotechnology. 10 indexed citations
13.
Xu, Shiyao, Yan Xiong, Rui Yao, et al.. (2022). A Novel ERK2 Degrader Z734 Induces Apoptosis of MCF–7 Cells via the HERC3/p53 Signaling Pathway. Molecules. 27(14). 4337–4337. 1 indexed citations
14.
15.
Wu, Haibo, et al.. (2021). Long non-coding RNA LINP1 promotes the malignant progression of prostate cancer by regulating p53. SHILAP Revista de lepidopterología. 2 indexed citations
16.
Jin, Changzhong, Tiansheng Xie, Wolfgang Fuchs, et al.. (2016). Severe dyslipidemia and immune activation in HIV patients with dysglycemia. HIV Clinical Trials. 17(5). 189–196. 11 indexed citations
17.
Luo, Chao, et al.. (2016). Neuroprotective role of muscone at early phase after traumatic brain injury in rats. Zhonghua chuangshang zazhi. 32(6). 547–551. 1 indexed citations
18.
Wu, Haibo, Yongsheng Wang, Yan Zhang, et al.. (2015). TALE nickase-mediated SP110 knockin endows cattle with increased resistance to tuberculosis. Proceedings of the National Academy of Sciences. 112(13). E1530–9. 132 indexed citations
19.
Yin, Songna, Haibo Wu, Xinying Wu, et al.. (2014). SHP-1 Arrests Mouse Early Embryo Development through Downregulation of Nanog by Dephosphorylation of STAT3. PLoS ONE. 9(1). e86330–e86330. 17 indexed citations
20.
Cai, Zhigang, et al.. (2013). Aberrant expression of microRNAs involved in epithelial–mesenchymal transition of HT‐29 cell line. Cell Biology International. 37(7). 669–674. 26 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026